How does emerging patent case law in the US and Europe affect precision medicine?: How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

Mateo Aboy; Glenn  Cohen; Kathleen Liddell; Johnathan Liddicoat; Cristina Crespo; Sara Gerke; Timo Minssen

doi:10.1038/s41587-019-0265-1

How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

Mateo Aboy, Glenn Cohen, Kathleen Liddell, Johnathan Liddicoat, Cristina Crespo, Sara Gerke, Timo Minssen

4 Citationer (Scopus)

Abstract

Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future of
precision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.

Originalsprog	Engelsk
Tidsskrift	Nature Biotechnology
Vol/bind	37
Udgave nummer	10
Sider (fra-til)	1118–1125
Antal sider	8
ISSN	1087-0156
DOI	https://doi.org/10.1038/s41587-019-0265-1
Status	Udgivet - 2 okt. 2019

Emneord

Det Juridiske Fakultet

Adgang til dokumentet

10.1038/s41587-019-0265-1

Andre filer og links

Fingeraftryk

Dyk ned i forskningsemnerne om 'How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Aboy, M., Cohen, G., Liddell, K., Liddicoat, J., Crespo, C., Gerke, S., & Minssen, T. (2019). How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? Nature Biotechnology, 37(10), 1118–1125. https://doi.org/10.1038/s41587-019-0265-1

How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? / Aboy, Mateo; Cohen, Glenn ; Liddell, Kathleen et al.
I: Nature Biotechnology, Bind 37, Nr. 10, 02.10.2019, s. 1118–1125.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Aboy, M, Cohen, G, Liddell, K, Liddicoat, J, Crespo, C, Gerke, S & Minssen, T 2019, 'How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?', Nature Biotechnology, bind 37, nr. 10, s. 1118–1125. https://doi.org/10.1038/s41587-019-0265-1

Aboy M, Cohen G, Liddell K, Liddicoat J, Crespo C, Gerke S et al. How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? Nature Biotechnology. 2019 okt. 2;37(10):1118–1125. doi: 10.1038/s41587-019-0265-1

@article{e380d499b22e4851a81b9573f6fdda05,

title = "How does emerging patent case law in the US and Europe affect precision medicine?: How will today{\textquoteright}s patent law affect tomorrow{\textquoteright}s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?",

abstract = "Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today{\textquoteright}s law will affect tomorrow{\textquoteright}s innovation.",

keywords = "Faculty of Law, pecision medicine, patents, Biomarkers, diagnostics, Artificial intelligence, big data, algorithm engineering",

author = "Mateo Aboy and Glenn Cohen and Kathleen Liddell and Johnathan Liddicoat and Cristina Crespo and Sara Gerke and Timo Minssen",

year = "2019",

month = oct,

day = "2",

doi = "10.1038/s41587-019-0265-1",

language = "English",

volume = "37",

pages = "1118–1125",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "nature publishing group",

number = "10",

}

TY - JOUR

T1 - How does emerging patent case law in the US and Europe affect precision medicine?

T2 - How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

AU - Aboy, Mateo

AU - Cohen, Glenn

AU - Liddell, Kathleen

AU - Liddicoat, Johnathan

AU - Crespo, Cristina

AU - Gerke, Sara

AU - Minssen, Timo

PY - 2019/10/2

Y1 - 2019/10/2

N2 - Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.

AB - Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.

KW - Faculty of Law

KW - pecision medicine

KW - patents

KW - Biomarkers

KW - diagnostics

KW - Artificial intelligence

KW - big data

KW - algorithm engineering

UR - https://rdcu.be/bSLBa

UR - https://www.nature.com/articles/s41587-019-0265-1

U2 - 10.1038/s41587-019-0265-1

DO - 10.1038/s41587-019-0265-1

M3 - Journal article

C2 - 31578504

SN - 1087-0156

VL - 37

SP - 1118

EP - 1125

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 10

ER -